Axsome Therapeutics (AXSM) Shares Outstanding (Diluted Average) (2020 - 2026)

Axsome Therapeutics' Shares Outstanding (Diluted Average) history runs 7 years deep, the most recent figure standing at $51.2 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 4.76% year-over-year to $51.2 million; the TTM figure through Mar 2026 stood at $51.2 million (up 4.76% YoY), while the FY2025 annual figure was $49.7 million, up 3.83% from the prior year.
• Shares Outstanding (Diluted Average) came in at $51.2 million for Q1 2026 at Axsome Therapeutics, up from $49.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $51.2 million in Q1 2026 to a low of $38.3 million in Q1 2022.
• A 5-year average of $45.8 million and a median of $47.4 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• Across the five-year window, Shares Outstanding (Diluted Average) increased 13.57% in 2023 and rose 1.24% in 2024, its largest moves.
• Axsome Therapeutics' Shares Outstanding (Diluted Average) stood at $40.7 million in 2022, then gained by 11.73% to $45.4 million in 2023, then climbed by 5.48% to $47.9 million in 2024, then increased by 3.83% to $49.7 million in 2025, then climbed by 2.92% to $51.2 million in 2026.
• According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $51.2 million, $49.7 million, and $50.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison